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Increased Pelvic Vein Thrombi in Cryptogenic Stroke
Results of the Paradoxical Emboli From Large Veins in Ischemic Stroke
(PELVIS) Study
Steven C. Cramer, MD; Guy Rordorf, MD; Jeffrey H. Maki, MD, PhD; Larry A. Kramer, MD;
James C. Grotta, MD; W. Scott Burgin, MD; Judith A. Hinchey, MD; Curtis Benesch, MD;
Karen L. Furie, MD; Helmi L. Lutsep, MD; Ellen Kelly, AA; W.T. Longstreth, Jr, MD
Background and Purpose—Cryptogenic stroke is associated with an increased prevalence of patent foramen ovale. The
Paradoxical Emboli From Large Veins in Ischemic Stroke (PELVIS) study hypothesized that patients with cryptogenic
stroke have an increased prevalence of pelvic deep venous thrombosis (DVT).
Methods—At 5 sites, patients 18 to 60 years of age received an MRI venogram (MRV) of the pelvis within 72 hours of
new symptom onset. Clinical data were then determined. Radiologists blinded to clinical data later read the scans.
Results—The 95 patients who met entry criteria were scanned. Their meanSD age was 4610 years, and time from
stroke onset to pelvic MRV scan was 4916 hours. Compared with those with stroke of determined origin (n49),
patients with cryptogenic stroke (n46) were significantly younger, had a higher prevalence of patent foramen ovale
(61% versus 19%), and had less atherosclerosis risk factors. Cryptogenic patients had more MRV scans with a high
probability for pelvic DVT (20%) than patients with stroke of determined origin (4%, P0.03), with most having an
appearance of a chronic DVT.
Conclusions—In this study of young stroke patients evaluated early after stroke, patients with cryptogenic stroke showed
differences in several clinical features compared with patients with stroke of determined origin, including increased
prevalence of pelvic DVT. The results require confirmation but suggest that paradoxical embolus from the pelvic veins
may be the cause of stroke in a subset of patients classified as having cryptogenic stroke. (Stroke. 2004;35:46-50.)
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No cause can be found in 26%1 to 40%2 of strokes and in64% of stroke patients 55 years of age.3 Numerous
studies have found that such cryptogenic stroke patients have
an increased prevalence of patent foramen ovale (PFO)
compared with patients with stroke of determined origin or
normal control subjects, and a meta-analysis found this
increase to be most significant in younger patients.4 A PFO is
an interatrial communication that might allow thromboemboli
to pass from the right to the left side of the heart. Patients with
PFO-related stroke have an increased prevalence of inherited
thrombophilic disorders.5 In patients with cryptogenic stroke,
features of brain imaging are often suggestive of embolus.2,6
These facts together suggest that passage of venous thrombus
to the cerebral arterial circulation might be the mechanism of
stroke in some patients whose infarct is currently classified as
cryptogenic, particularly younger patients. However, this
formulation has been criticized because a venous source of
thrombus has uncommonly been found in patients with stroke
and PFO.7
Several findings suggest that pelvic veins may be an
important source of thromboemboli in cryptogenic stroke.
Autopsy studies have documented isolated pelvic vein or
inferior vena cava thrombus in 16% of patients with pulmo-
nary emboli (PE)8 and 22% of patients with paradoxical
emboli in whom a source could be found.9,10 Clinical studies
have identified pelvic deep venous thrombosis (DVT) in
several populations,11–14 including cryptogenic PE,15,16 sug-
gesting that thrombi can form in pelvic veins and embolize.
More recently, pelvic DVT has also been described in series
of patients with cryptogenic stroke and PFO.17–20
Prior studies suggest that pelvic veins may be an important
source of thromboemboli and that the prevalence of PFO is
particularly increased in younger patients with cryptogenic
stroke. Limited information is available about pelvic DVT in
young stroke patients, cryptogenic or otherwise. The Paradoxical
Emboli From Large Veins in Ischemic Stroke (PELVIS) study
was designed to test the hypothesis that, in young patients with
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stroke, the prevalence of pelvic DVT is increased when stroke is
cryptogenic compared with when stroke is of determined origin.
Patients and Methods
Entry Criteria
Eligible patients were 18 to 60 years of age, had ischemic stroke72
hours in duration, and experienced deficits for 3 hours. The upper
age limit was selected because review of the literature suggested that
the association between PFO and cryptogenic stroke, a relationship
relevant to investigation of pelvic DVT, is weaker beyond this
cutoff; this value is similar to the upper age suggested in a recent
meta-analysis.4 Exclusion criteria were inability to undergo an MRI
scan, pregnancy, and stroke occurrence during hospitalization. An
MRI venogram (MRV) was performed within 72 hours of stroke
onset because studies suggest that formation of fresh DVT after
stroke is uncommon when the interval is 3 days after stroke.21,22
Subsequently, a stroke neurologist ordered testing according to local
practice standards to identify cause of stroke and classify23 stroke
subtype. Clinical data were collected prospectively. Each site at-
tempted to enroll consecutive patients meeting entry criteria. In-
formed consent was obtained in all cases in accordance with local
institutional review board requirements.
Clinical Assessments
Of 109 patients enrolled, 10 were determined not to have had a
stroke, and 4 others could not be scanned, leaving 95 patients (Table
1) for these analyses. Four of these 95 patients were enrolled 72
hours after stroke but for technical reasons could not be scanned until
0 to 6 hours beyond the 72-hour cutoff. These 4 patients are included
in current analyses because excluding them did not change signifi-
cant findings. In 52% of patients (49 of 95), a cause of stroke was
identified, whereas 48% (46 of 95) were classified as cryptogenic.
Enrollment began September 1999 with 2 centers; 3 others were
added mid-2000. Enrollment concluded February 2002.
MRV Acquisition
MRVs were acquired with a GE 1.5-T system and a phased-array
torso coil to provide insights into venous structure and flow.
Scanning consisted of 2-dimensional axial time-of-flight (TOF) and
phase-contrast (PC) pulse sequences. The field of view extended 24
cm inferiorly from the infrarenal inferior vena cava to the common
femoral vein just inferior to the inguinal ligament. In-plane resolu-
tion was 1.52.5 mm. For TOF images, a spoiled gradient-echo
pulse sequence was used. Slices were 3 mm with 2-mm skip;
repetition time was 47; and echo time was 3.5 ms. For PC images,
slices were 5 mm thick without skip; slices were registered to TOF
slices; repetition time was 45 ms; and echo time was 7.5 ms. PC
images used a superior saturation band and velocity encoding value
of 20 cm/s. Both pulse sequences used a 60° flip angle and 1 signal
average. No contrast injection was used. MRV signal is affected by
plane, caliber, and flow velocity of veins. MRV in the present study
provided consistent data from external iliac veins, common iliac
veins, and a portion of the inferior vena cava; a very short segment
of the common femoral vein was also studied per the field of view.
Internal iliac veins were seen to a lesser degree, and paraprostatic/
parauterine veins could not be consistently evaluated.
MRV Interpretation
Pelvic MRV images were reviewed by 2 radiologists (J.H.M.,
L.A.K.) specializing in abdominal-pelvic imaging who were blinded
to all clinical data. Each radiologist was randomly assigned half of
the scans not acquired in his own institution. Before study enroll-
ment, the radiologists devised criteria for acute and chronic pelvic
DVT and then refined these criteria after reviewing pelvic MRV
scans from a separate study.20 Final criteria were similar to prior
definitions for acute11 and chronic24 DVT.
Scans were judged as being high probability for pelvic DVT when
there were at least 3 contiguous slices with a venous defect that was
matched on TOF and PC images. A scan with intermediate proba-
bility for pelvic DVT had matched defects on only 2 contiguous
slices. High-probability MRV scans were further classified as acute
if the venous defect was a mural-based filling defect or as chronic if
the vessel was narrowed without compression, often accompanied by
circumferential thickening and/or collateral vessels. After final study
interpretation of all scans, MRV scans with a high probability for
DVT, along with 34 negative scans, were overread to assess
interrater reliability.
Statistical Analysis
Continuous variables were compared with a t test; categorical variables,
with Fisher’s exact test or 2 test. All analyses were 2 tailed.
Results
Clinical assessments identified cause of stroke in 49 patients,
representing 52% of total study population. Of these 49, 33%
were due to a large-vessel event; 39%, a small-vessel event;
22%, a cardioembolic event; and 6%, another defined cause.
In 1 patient, 2 possible causes for stroke were identified. No
cause of stroke could be found in 46 patients (48% of the
study population), the cryptogenic stroke group.
Patients with cryptogenic stroke were clinically distinct
compared with patients with stroke of determined origin; they
were 7 years younger and had significantly lower atheroscle-
rosis risk factor prevalence. Several venous thrombosis risk
factors such as recent travel or miscarriage showed a trend
toward higher frequency in patients with cryptogenic stroke
(Table 1).
Echocardiography was performed in 92% of patients (Ta-
ble 2), including 44 of 46 patients (96%) with cryptogenic
stroke. In 2 patients, interatrial shunt was diagnosed by
transcranial Doppler. The prevalence of any interatrial shunt
TABLE 1. Characteristics of Study Population
Cause of Stroke
P *
Determined
(n49)
Cryptogenic
(n46)
Age (SD), y 49 (7) 42 (11) 0.0002
Male, % 55 50 0.70
Prior history of
Stroke, % 24 4 0.008
Hypertension, % 73 26 0.0001
Diabetes mellitus, % 22 13 0.3
Hyperlipidemia, % 26 11 0.11
Coronary artery disease, % 18 4 0.052
Smoking, pack-year 17 (24) 7 (13) 0.02
Miscarriage,† % 10 22 0.4
Recent travel,‡ % 11 24 0.11
New antibiotic prescription,§ % 6 9 0.7
On exogenous estrogen, % 27 22 0.7
Current diagnosis of malignancy, % 0 2 0.48
History of DVT or PE, % 8 4 0.68
Values that are not a percent are mean.
*Based on 2-tailed t test or 2 test. No missing values.
†Among women only, who represented 22 patients with stroke of deter-
mined cause and 23 cryptogenic stroke patients.
‡A 3-hour car or plane trip in prior 2 weeks.
§Initiated in prior 2 weeks.
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(PFO or atrial septal defect) across the study was 39%, with
the rate in cryptogenic stroke patients (61%) being 3 times
higher than in patients with stroke of determined origin.
Hypercoagulation testing was performed inconsistently
across patients, with 23% of patients receiving 0 of the 6 tests
recorded by the study (anticardiolipin antibody IgG and IgM,
activated protein C resistance, and levels of protein C, protein
S, and antithrombin III). Leg vein duplex, ordered per clinical
judgment, identified 1 leg DVT.
The 95 patients underwent pelvic MRV 48.916.1 hours
after stroke onset. Scanning did not conform to the protocol in
13 patients: The entire infrarenal inferior vena cava was not
visualized in 9 patients, a superior saturation band was
applied to both TOF and PC images in 3 patients, and only
TOF images were acquired in 1 patient with a normal scan.
A pelvic DVT (the Figure) was present with high proba-
bility in 11 patients (Table 3). The prevalence of pelvic DVT
was significantly higher (P0.025) in patients with crypto-
genic stroke (9 of 46, 20%) than in patients with stroke of
determined origin (2 of 49, 4%). The difference in percent-
ages was significant whether we considered only scans with
a high probability for DVT (difference, 16%; 95% confidence
interval [CI], 3.2 to 28.8) or scans with intermediate or high
probability for DVT (difference, 18%; 95% CI, 3.2 to 32.8).
When only the 39% of study patients with PFO or atrial septal
defect were examined, a pelvic DVT was present more often
in patients with cryptogenic stroke, but this difference was
not significant (Table 3).
In the 11 patients with high probability for pelvic DVT,
MRV were acquired a mean of 41.7 hours after stroke onset.
Thrombi involved external iliac vein in 6, common iliac vein
in 4, and internal iliac vein in 1. Most DVT had a chronic
appearance. Three of these 11 patients had received intrave-
TABLE 2. Clinical Assessments
Cause of Stroke
P *
Determined
(n49)
Cryptogenic
(n46)
NIH Stroke Scale score at study entry 4 4 0.80
Weight (SD), lb 192 (42) 173 (44) 0.03
First serum BUN/Cr 16 (6) 15 (6) 0.20
First serum glucose, mg/dL 134 (50) 120 (46) 0.15
Stroke diameter, mm 35 (32) 31 (27) 0.50
Treated with IV tPA, % 20 17 0.80
Echocardiogram, %
Done 86 96 0.16
Transthoracic 51 33
Transesophageal 24 50
Transthoracicesophageal 10 13
Atrial septal aneurysm present 0 9 0.11
PFO present 19 59 0.0002
ASD present 0 2 1.0
Leg venous duplex, %
Done 20 52 0.002
Leg vein DVT present 2 0 0.30
Any of 6 hypercoagulation tests
abnormal, %
16 27 0.39
NIH indicates National Institutes of Health; BUN, blood urea nitrogen; and
ASD, atrial septal defect. Values that are not percent are mean, except NIH
Stroke Scale score (median).
*Based on 2-tailed t test or 2 test. No missing values.
MRV images from 2 cryptogenic stroke patients with
pelvic DVT. Top row shows 3 contiguous PC MRV
images; bottom row, coplanar TOF images. Long
arrows indicate affected vein, which was left com-
mon iliac vein for both; short arrows, normal (right)
common iliac vein. Left to right is in the direction
from the heart to the foot. A, Patient with high prob-
ability for acute DVT. Left common iliac vein has a
mural-based filling defect. Superior saturation band
was inadvertently applied to TOF images, diminish-
ing signal from arteries. B, Patient with high proba-
bility for chronic DVT. Left common iliac vein is nar-
rowed. Arrowheads indicate common iliac arteries
that, unlike the veins, are symmetrical.
TABLE 3. MRV Results
Cause of Stroke
P*Determined Cryptogenic
High probability for pelvic DVT, n
(%)
2/49 (4) 9/46 (20) 0.025
Acute DVT 0/47 (0) 3/40 (7) 0.093
Chronic DVT 2/49 (4) 6/43 (13) 0.140
High probability for pelvic DVT in
presence of PFO or ASD, n (%)
0/9 (0) 6/28 (21) 0.302
High or intermediate probability
for pelvic DVT, n (%)
4/49 (8) 12/46 (26) 0.028
*Using 2-tailed Fisher’s exact test.
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nous tissue plasminogen activator (tPA) for acute stroke; in
all 3, DVT had a chronic appearance. The 11 patients with
high probability for pelvic DVT compared with the 84 other
patients had a higher NIH stroke scale score (8.26.5 versus
4.94.5, P0.04). Of these 11, none had a prior stroke or
DVT, and no DVT risk factor was significantly different
compared with patients without a pelvic DVT, although there
was a trend toward a higher rate of prior miscarriage among
female patients with a pelvic DVT (67% versus 12%,
P0.062). During interrater reliability assessments, the sec-
ond radiologist found a high probability for DVT in 4 of the
11 MRVs initially diagnosed with a high probability for
pelvic DVT and found the scan to be negative in 29 of the 34
MRVs that were initially negative for DVT. With these
values, 0.23, representing a fair25 level of interrater
agreement.
Of the 9 cryptogenic stroke patients with high probability
for pelvic DVT, all underwent echocardiographic evaluation,
which showed PFO in 6. Of the remaining 3 patients, features
of history suggested DVT in 2: 1 had an airplane flight the
day before stroke and was assessed by transthoracic echocar-
diogram, and 1 had a history of spontaneous abortion. All 6
hypercoagulation tests were performed in 7 of 9, normal in all
cases.
Of the 2 patients with stroke of determined origin and high
probability for pelvic DVT, both had a large-artery stroke,
had chronic appearance to pelvic DVT, received intravenous
tPA acutely, and had PFO by transthoracic echocardiogram.
Discussion
A number of studies have found that PFO is present with
increased frequency in patients with cryptogenic stroke.4 This
increase suggests that, in some of these patients, a venous
thrombus may be crossing to the arterial circulation and
causing stroke. In the present study, MRV was used to
evaluate pelvic veins early after stroke onset. Compared with
patients with stroke of determined origin, patients with
cryptogenic stroke had a significantly increased frequency of
pelvic DVT.
The prevalence of DVT in prior studies of patients with
PFO and cryptogenic stroke has varied widely, possibly
because a consistent evaluation of the venous system was not
performed early after stroke onset. Gautier et al26 performed
venography 2 days to 7 months after cryptogenic transient
ischemic attack or stroke and found that 3 of 23 patients with
PFO had leg DVT and 3 had common iliac vein compression.
Ranoux et al27 performed venography within 4 weeks of
cryptogenic stroke and found that 1 of 13 patients with PFO
had leg DVT. Lethen et al28 performed venography an
average of 8 days after transient ischemic stroke or stroke of
suspected cardiac origin and found that 5 of 53 patients with
PFO had iliac or calf DVT. Stollberger et al29 found leg or
pelvic DVT in 19 of 29 patients with PFO days to months
after cryptogenic arterial embolus. The present study found
pelvic DVT a mean of 2 days after stroke in 9 of 46 patients
with cryptogenic stroke and in 6 of 28 patients with crypto-
genic stroke and PFO.
Isolated pelvic DVT has historically been considered rare
but recently has been increasingly recognized as an important
clinical entity. The infrequency with which pelvic DVT has
been diagnosed in the past may be due to a number of
reasons,30 particularly the limited sensitivity of contrast
venography, 125I-fibrinogen scanning, and Doppler for DVT
in the pelvic veins.11,31–33 However, autopsy studies have
found that pelvic veins were the only embolic source in 19 of
86 patients (22%) with paradoxical embolism in whom a
source could be found,9,10 and isolated pelvic DVT was found
in 16% of patients with PE.8 Spritzer et al,11 in 769 consec-
utive MRV studies of the entire leg and pelvis, found that
20% of DVT were isolated to the pelvic veins.
Several factors may have reduced the likelihood of diag-
nosing pelvic DVT in the present study. Rates of intravenous
tPA (Table 2) were 10-fold greater than the US average,34
which may have dissolved some DVT before MRV. Interrater
reliability for MRV interpretation was not high despite efforts
to refine MRV diagnostic criteria and intersite consistency of
MRI manufacturer/field strength. This may have reduced the
strength of the association observed between a diagnosis of
pelvic DVT and particular stroke subtypes. Newer methods
for evaluating pelvic DVT16,35–37 might show improved in-
terrater reliability and therefore might identify a stronger
relationship between pelvic DVT and cryptogenic stroke.
The present study found that patients with cryptogenic
stroke have an increased prevalence of pelvic DVT compared
with patients with stroke of determined origin. Most patients
with cryptogenic stroke and pelvic DVT also had a PFO, a
combination of results that suggests paradoxical embolism as
the stroke mechanism. Strengths of the study include imaging
before the time when most DVT develops after stroke and a
focus on younger patients in whom the connection between
PFO and cryptogenic stroke is stronger.4 Weaknesses of the
study include the absence of a screening log, which compli-
cates generalization of study results, and lack of data on
prestroke antithrombotic medication usage, which, if differ-
ent across groups (as suggested by risk factor imbalances in
Table 1), might explain in part the lower DVT rate among
patients with stroke of determined origin. Also, the study
would have provided greater insight into the significance of
pelvic DVT and might have been more precise in classifying
strokes as cryptogenic if echocardiography, hypercoagulable
testing, leg vein duplex, and carotid duplex had been stan-
dardized and if maximally sensitive methods38 had been used
to search for a PFO. Furthermore, such an approach might
have lent clarity to the diagnosis of pelvic DVT in the 3
cryptogenic stroke patients who were not diagnosed with
PFO.
A substantial number of patients continue to be discharged
without knowledge of stroke mechanism.1–3 The present
results suggest that paradoxical embolus from the pelvic
veins may be the cause of stroke in a subset of patients
classified as having cryptogenic stroke.
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